[Brachytherapy of prostatic carcinoma, 60Co high dose rate, remote after-loading methods].
Six patients with prostatic carcinoma, including 2 with Stage B, 2 with Stage C, 2 with Stage D1, received transurethral irradiation (TUI) using 60Co high dose rate, remote afterloading methods, in combination with external irradiation by 4 MV X-ray. Total tumor doses were 97.0 to 129.3 in TDF and needle biopsy performed 3 mo after the treatment proved to be free of cancer cell in 5 patients and almost no viable cancer cell in one patient. No adverse reactions were encountered in any patient. We believe that TUI is a useful treatment for prostatic carcinoma.
Kosuda
S
S
Department of Radiology, Tokyo Metropolitan Komagome Hospital.
Kawahara
S
S
Tamura
K
K
Dokiya
T
T
Andoh
Y
Y
Hashimoto
S
S
D000368:Aged; D001918:Brachytherapy / Q000295:instrumentation / Q000379:methods; D003037:Cobalt Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011879:Radiotherapy Dosage
D003037:Cobalt Radioisotopes